1.208.631.2390 don@db-insurance.com
  • Facebook
  • Facebook
DB Northwest
  • Enrollment and Quotes
    • Disability Income
    • Medicare
  • Idaho health insurance
  • FAQ
    • Blog
  • Call Now!
  • Leave A Review
  • Contact
Select Page

Judge allows Missouri's only abortion clinic to stay open for at least five more days

by DB Insurance | Jun 25, 2019 | Uncategorized

A Missouri judge ruled on Monday the state’s only abortion clinic can remain open for at least five more days, but he ordered Planned Parenthood to take its fight against closure to a state arbiter.

Medical cannabis group EMMAC forms research partnership with Hyris Ltd

by DB Insurance | Jun 24, 2019 | Uncategorized

European medical cannabis company EMMAC announced on Monday a research partnership with UK biotechnology company Hyris Limited to develop a library of genetic profiles of existing cannabis varieties.

Thailand bans pig imports from Laos after African swine fever outbreak

by DB Insurance | Jun 23, 2019 | Uncategorized

Thailand will ban pig imports from Laos for 90 days after its neighbor confirmed the first outbreak of deadly African swine fever, an official notice said.

FDA approves drug for loss of sexual desire in women

by DB Insurance | Jun 22, 2019 | Uncategorized

The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals’ drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy that some have dubbed as “female Viagra”.

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

by DB Insurance | Jun 21, 2019 | Uncategorized

Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted.
« Older Entries
Next Entries »

Search

Recent Posts

  • Samoa extends measles state of emergency, NZ to fund Pacific vaccination campaign
  • Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
  • U.S. FDA gives early approval to Sarepta's newest DMD treatment
  • Home is now the most common place of death in the U.S.
  • U.S. Supreme Court justices lean toward insurers on $12 billion Obamacare claims
  • J&J CEO spurns U.S. congressional hearing on carcinogens in talc products
  • Health experts warn of emerging threat of Nipah virus
  • Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
  • Weight-loss surgery between pregnancies tied to better outcomes
  • FDA probes diabetes drug metformin for carcinogen NDMA
  • Hospital groups file lawsuit to block Trump's price transparency rule
  • Malaria fight stalling at 'unacceptably high level' of deaths: WHO
  • U.S. considers easing drug protection to break deadlock over trade pact: Wall Street Journal
  • Bangladesh plans to ban e-cigarettes amid growing health concerns
  • China to use drug bulk-buy program to close price gap
  • Drinking-related liver disease and deaths on the rise in U.S.
  • Four killed in attacks against Ebola response centers in Congo
  • MRI spots tumors in women with dense breasts, but false positives a problem
  • U.S. judge partially overturns conviction of opioid maker Insys' founder
  • FDA approves Global Blood Therapeutics's sickle cell disease drug

Archives

  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • July 2018
  • Facebook

© DB Insurance